e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
COPD treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
V. Abdullayev, G. Aliyeva (Baku, Azerbaijan)
Source:
Annual Congress 2013 –COPD treatment
Session:
COPD treatment
Session type:
Thematic Poster Session
Number:
3684
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Abdullayev, G. Aliyeva (Baku, Azerbaijan). The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2013; 42: Suppl. 57, 3684
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
COPD and CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Reasons for hospitalisation patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Heart rhythm disorders in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment?
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept